Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Tonix Pharma (TNXP)
NASDAQ:TNXP
Tonix Pharma (TNXP) Stock Price & Analysis
2,062 Followers
TNXP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.29 - $7.74
Previous Close$0.58
Volume359.74K
Average Volume (3M)3.73M
Market Cap
$36.10M
Enterprise Value-$83.37M
Total Cash (Recent Filing)$120.23M
Total Debt (Recent Filing)$760.00K
Price to Earnings (P/E)-0.1
Beta2.35
Next Earnings
May 15, 2023EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.09
Shares Outstanding62,663,898
10 Day Avg. Volume1,049,816
30 Day Avg. Volume3,733,992
Standard Deviation0.39
R-Squared0.09
Alpha-0.10
Financial Highlights & Ratios
Price to Book (P/B)0.17
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.75
Forecast
1Y Price Target
$6.50Price Target Upside1026.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Tonix Pharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TNXP FAQ
What was Tonix Pharma’s price range in the past 12 months?
Tonix Pharma lowest stock price was $0.29 and its highest was $7.74 in the past 12 months.
What is Tonix Pharma’s market cap?
Currently, no data Available
When is Tonix Pharma’s upcoming earnings report date?
Tonix Pharma’s upcoming earnings report date is May 15, 2023 which is in 49 days.
How were Tonix Pharma’s earnings last quarter?
Tonix Pharma released its earnings results on Mar 13, 2023. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.86 by $0.3.
Is Tonix Pharma overvalued?
According to Wall Street analysts Tonix Pharma’s price is currently Undervalued.
Does Tonix Pharma pay dividends?
Tonix Pharma does not currently pay dividends.
What is Tonix Pharma’s EPS estimate?
Tonix Pharma’s EPS estimate is -$0.53.
How many shares outstanding does Tonix Pharma have?
Tonix Pharma has 62,539,497 shares outstanding.
What happened to Tonix Pharma’s price movement after its last earnings report?
Tonix Pharma reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.86. Following the earnings report the stock price went up 12.903%.
Which hedge fund is a major shareholder of Tonix Pharma?
Currently, no hedge funds are holding shares in TNXP
---
Tonix Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.50 (1026.13% Upside)
$6.50 (1026.13% Upside)
Blogger Sentiment
Bullish
TNXP Sentiment 100%
Sector Average 68%
Sector Average 68%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-92.41%
12-Months-Change
Fundamentals
Return on Equity
-51.76%
Trailing 12-Months
Asset Growth
-6.31%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tonix Pharma
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.
---
Top 5 ETFs holding TNXP
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold TNXP. The ETFs are listed according to market value of TNXP within the ETF
---
Theralink Technologies
―
Sio Gene Therapies
―
Harpoon Therapeutics
―
Oragenics
―
Jasper Therapeutics
―
---